Devank Pharmaceuticals Private Limited
About Devank Pharmaceuticals Private Limited
Data last updated:
Devank Pharmaceuticals Private Limited is a private limited company based in Gautam Buddh Nagar, Uttar Pradesh, India. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 25 January 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Kanpur, under CIN U24290UP2019PTC112804. Its GSTIN is 09AAHCD0615N2ZH (Uttar Pradesh). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹2 Lakh. It is led by directors Nripendra Bahadur Singh and Pragati Singh.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at C/O Pratima Singh W/O Rohit Kumar Ganga Vihar Dadri, Gautam Buddh Nagar, Uttar Pradesh, India – 203207.
As per the financials filed for FY 2024, the company reported a revenue of ₹6.65 Lakh, a decline of 31% compared to the previous year. For the same year it recorded a net loss of ₹8,083 (net margin -1.2%) and EBITDA of ₹20,726 (EBITDA margin 3.1%). Revenue has declined at a compounded annual rate (CAGR) of 6% over three years.
Court records list 1 case involving the company, including 1 filed against it.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressC/O Pratima Singh W/O Rohit Kumar Ganga Vihar Dadri, Gautam Buddh Nagar, Uttar Pradesh, India – 203207
- IndustryChemicals, Manufacturing, Other Chemical Product
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Devank Pharmaceuticals Private Limited
The main business activity of Devank Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Devank Pharmaceuticals Private Limited FY 2025 filings available
Devank Pharmaceuticals Private Limited reported revenue of ₹6.65 Lakh (down 31% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR) of Devank Pharmaceuticals Private Limited
Revenue has declined at a compounded annual rate (CAGR) of 6% over three years, including a 31% fall in the latest year. EBITDA rose 5% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Devank Pharmaceuticals Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹20,726 | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹8,083 | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Devank Pharmaceuticals Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 3.1% | •••• | •••• | •••• | •••• |
| Net Profit Margin | -1.2% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Devank Pharmaceuticals are in the company report.
Financial statements from FY 2019
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Devank Pharmaceuticals Private Limited
Devank Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Excelencia Pharmaceuticals Private Limited | ₹6.67 Lakh (FY 2025) | •••• | •••• | -69.0% | •••• | Ahmedabad, Gujarat, India |
| Themicure Pharmaceuticals Private Limited | ₹6.67 Lakh (FY 2025) | •••• | •••• | -56.0% | •••• | Pune, Maharashtra, India |
| Sabiscon Pharmaceuticals Private Limited | ₹6.66 Lakh (FY 2025) | •••• | •••• | 2.0% | •••• | Surat, Gujarat, India |
| Tacaso Pharmaceuticals Private Limited | ₹6.65 Lakh (FY 2025) | •••• | •••• | 202.0% | •••• | Salem, Tamil Nadu, India |
| Zeltron Pharmaceuticals Private Limited | ₹6.65 Lakh (FY 2021) | •••• | •••• | -78.0% | •••• | Ahmedabad, Gujarat, India |
| Devank Pharmaceuticals Private Limited this company | ₹6.65 Lakh (FY 2024) | •••• | •••• | -31.0% | •••• | Gautam Buddh Nagar, Uttar Pradesh, India |
| Unigrap Pharmaceuticals Private Limited | ₹6.65 Lakh (FY 2025) | •••• | •••• | -7.0% | •••• | Ahmedabad, Gujarat, India |
| Medwave Pharmaceuticals Private Limited | ₹6.64 Lakh (FY 2020) | •••• | •••• | 36.0% | •••• | Delhi, India |
| Hafwen Pharmaceuticals Private Limited | ₹6.63 Lakh (FY 2017) | •••• | •••• | •••• | Hyderabad, Telangana, India | |
| Shivanjali Healthcare & Pharmaceuticals Private Limited | ₹6.63 Lakh (FY 2025) | •••• | •••• | 131.0% | •••• | Mumbai, Maharashtra, India |
| Ratantray Pharmaceuticals Private Limited | ₹6.62 Lakh (FY 2025) | •••• | •••• | 12.0% | •••• | Jaipur, Rajasthan, India |
Peers are the five companies nearest above and the five nearest below Devank Pharmaceuticals by revenue in the Pharma industry (Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Board of Directors of Devank Pharmaceuticals Private Limited
Devank Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Nripendra Bahadur Singh | Director | 25 Jan 2019 | 7 Years 8 Months | Current |
| Pragati Singh | Director | 25 Jan 2019 | 7 Years 8 Months | Current |
Ownership and Shareholding of Devank Pharmaceuticals Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Devank Pharmaceuticals Private Limited
Devank Pharmaceuticals Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Legal Cases of Devank Pharmaceuticals Private Limited
Devank Pharmaceuticals Private Limited has 1 court case on record: 1 filed against it. All case is disposed. Status as checked on 01 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 1 | 0 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Ambala, Haryana | Commercial suit | Filed against the company by Varmed Pharma Private Limited | Disposed |
Full case history
All 1 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Employees and EPFO Compliance at Devank Pharmaceuticals Private Limited
Employment history and EPFO contributions of people linked to Devank Pharmaceuticals.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Devank Pharmaceuticals Private Limited
Devank Pharmaceuticals Private Limited has 2 board changes on record since 2019: 2 appointments. The latest: Nripendra Bahadur Singh was appointed as Director on 25 Jan 2019.
Credit Ratings, Litigation & Regulatory Alerts for Devank Pharmaceuticals Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Devank Pharmaceuticals Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Devank Pharmaceuticals Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Devank Pharmaceuticals Private Limited
Devank Pharmaceuticals has 2 GST registrations: 1 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AAHCD0615N2ZH | Uttar Pradesh | Active | 07 Feb 2020 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Devank Pharmaceuticals Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Devank Pharmaceuticals Private Limited
Devank Pharmaceuticals is an active private limited company based in Gautam Buddh Nagar, Uttar Pradesh, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 25 January 2019 (7+ years old) and is registered under CIN U24290UP2019PTC112804.
Devank Pharmaceuticals reported revenue of ₹6.65 Lakh for FY 2024 (down 31% YoY).
Devank Pharmaceuticals has 2 current directors:
- Nripendra Bahadur Singh - Director
- Pragati Singh - Director
Devank Pharmaceuticals reported a net loss of ₹8,083 (net margin -1.2%) and EBITDA of ₹20,726 (EBITDA margin 3.1%) for FY 2024, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Devank Pharmaceuticals is -6% over three years. In the latest year (FY 2024) revenue fell 31%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Devank Pharmaceuticals is 09AAHCD0615N2ZH, registered in Uttar Pradesh. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Devank Pharmaceuticals is U24290UP2019PTC112804. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Devank Pharmaceuticals has 1 court case on record: 1 filed against it.
Devank Pharmaceuticals was incorporated on 25 January 2019, making it 7+ years old. It is registered with the Registrar of Companies, Kanpur.
The peers of Devank Pharmaceuticals by revenue are Excelencia Pharmaceuticals Private Limited, Themicure Pharmaceuticals Private Limited, Sabiscon Pharmaceuticals Private Limited, Tacaso Pharmaceuticals Private Limited, Zeltron Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Pharmaceuticals).
Nripendra Bahadur Singh was appointed as Director on 25 Jan 2019. Pragati Singh was appointed as Director on 25 Jan 2019.